Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.

Hsi-Che LiuMing-Chung KuoKang-Hsi WuTsai-Yun ChenJiann-Shiuh ChenMing-Chung WangTung-Liang LinYoungSen YangMing-Chun MaPo-Nan WangJiunn-Ming SheenShih-Chung WangShih-Hsiang ChenTang-Her JaingChao-Neng ChengTing-Chi YehTung-Huei LinLee-Yung Shih

Published in: British journal of cancer (2023)

We demonstrated the paediatric cohort had slower molecular responses to front-line IM and similar outcomes in 10-year PFS and OS in real-world practice.

Keyphrases

young adults
healthcare
emergency department
bone marrow
dendritic cells
single molecule
acute myeloid leukemia
cross sectional
quality improvement
weight loss
glycemic control